bimatoprost/brimonidine / AbbVie  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bimatoprost/brimonidine / AbbVie
NCT01863953: A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

Completed
2
112
US
Fixed-Combination Bimatoprost/Brimonidine, Bimatoprost Ophthalmic Solution 0.01%, LUMIGAN, Vehicle Ophthalmic Solution, Brimonidine Tartrate Ophthalmic Solution 0.2%, ALPHAGAN
Allergan
Glaucoma, Ocular Hypertension
12/13
12/13

Download Options